| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
58.08 |
B.V. (₹) |
391.10 |
| Sales(₹ Cr.) |
11,171.72 |
NP (₹ Cr.) |
2,426.73 |
| NP Var% |
40.00 |
Div% |
400.00 |
| CPS(₹) |
46.70 |
EPS (₹) |
41.80 |
| Traded Value(₹ Lakhs) |
1,969.67 |
52 Week High |
1,661.00 |
| 52 Week Low |
1,017.00 |
Price BSE |
1,661.00 |
| Price NSE |
1,658.00 |
Market Capital (₹ Cr.) |
96,471.15 |
| P/C Ratio |
35.60 |
P/E Ratio |
39.80 |
| Price Vs.BV |
4.25 |
|
| Latest Quarter |
| Year End |
202606 |
Sales (₹ Cr.) |
2,781.69 |
| NP(₹ Cr.) |
737.22 |
NP Var % |
32.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
10,713.37 |
| OPM |
23.28 |
NP |
2,069.02 |
| NP Var% |
31.81 |
EPS |
44.86 |
| PE |
37.03 |
|
|